Compare CVS Health Corp (CVS) vs iShares iBoxx $ Inv Grade Corporate Bond ETF (LQD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs iShares iBoxx $ Inv Grade Corporate Bond ETF — how do they compare? CVS Health Corp trades at $86.3 (market cap $112.49B), while iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $102.47 (market cap $27.76B). The key difference: CVS Health Corp is far larger — about 4.1× iShares iBoxx $ Inv Grade Corporate Bond ETF's market cap, and CVS Health Corp pays a 3.02% dividend while iShares iBoxx $ Inv Grade Corporate Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and iShares iBoxx $ Inv Grade Corporate Bond ETF for 125 Days on average.
| CVS | LQD | |
|---|---|---|
Market Cap | $112.49B | $27.76B |
Volume | 8,467,392 | 30,088,564 |
Sector | Health | Fixed Income |
52-Week High | $110.60 | $112.91 |
52-Week Low | $70.08 | $101.83 |
Typical Hold Time | 83 Days | 125 Days |
Enterprise Value | $174.83B | — |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
LQD trades at $102.12, down 0.02% on the day, amid a bearish technical signal with moving averages indicating selling pressure and oscillators neutral. The ETF faces headwinds from rising bond yields and a significant 53.1% increase in short interest reported as of September 15, 2026. Recent dividends include $0.44 and $0.46 payouts scheduled through October 2026, providing income support.
Outlook remains cautious due to persistent bond market volatility and higher interest rates, which pressure corporate bond ETFs. Investment opportunities lie in the 4.8% yield and high-quality portfolio, but risks include further yield spikes and economic slowdowns affecting credit quality.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About iShares iBoxx $ Inv Grade Corporate Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →
